ENGOT-OV24/NSGO-AVANOVA1
Trial Description:
Niraparib and niraparib-bevacizumab combination against bevacizumab alone in Women with Homologous Recombination Deficient (HRD) platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed
Contact person:
mraza